302 related articles for article (PubMed ID: 36697369)
1. Positive-strand RNA viruses-a Keystone Symposia report.
Cable J; Denison MR; Kielian M; Jackson WT; Bartenschlager R; Ahola T; Mukhopadhyay S; Fremont DH; Kuhn RJ; Shannon A; Frazier MN; Yuen KY; Coyne CB; Wolthers KC; Ming GL; Guenther CS; Moshiri J; Best SM; Schoggins JW; Jurado KA; Ebel GD; Schäfer A; Ng LFP; Kikkert M; Sette A; Harris E; Wing PAC; Eggenberger J; Krishnamurthy SR; Mah MG; Meganck RM; Chung D; Maurer-Stroh S; Andino R; Korber B; Perlman S; Shi PY; Bárcena M; Aicher SM; Vu MN; Kenney DJ; Lindenbach BD; Nishida Y; Rénia L; Williams EP
Ann N Y Acad Sci; 2023 Mar; 1521(1):46-66. PubMed ID: 36697369
[TBL] [Abstract][Full Text] [Related]
2. Potent Inactivation of Human Respiratory Viruses Including SARS-CoV-2 by a Photoactivated Self-Cleaning Regenerative Antiviral Coating.
Kumar U; Fox CR; Kolanthai E; Neal CJ; Kedarinath K; Fu Y; Marcelo E; Babu B; Parks GD; Seal S
ACS Appl Mater Interfaces; 2022 Sep; 14(36):40659-40673. PubMed ID: 36004755
[TBL] [Abstract][Full Text] [Related]
3. Outbreaks of publications about emerging infectious diseases: the case of SARS-CoV-2 and Zika virus.
Ipekci AM; Buitrago-Garcia D; Meili KW; Krauer F; Prajapati N; Thapa S; Wildisen L; Araujo-Chaveron L; Baumann L; Shah S; Whiteley T; Solís-García G; Tsotra F; Zhelyazkov I; Imeri H; Low N; Counotte MJ
BMC Med Res Methodol; 2021 Mar; 21(1):50. PubMed ID: 33706715
[TBL] [Abstract][Full Text] [Related]
4. Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates.
Marlin R; Desjardins D; Contreras V; Lingas G; Solas C; Roques P; Naninck T; Pascal Q; Behillil S; Maisonnasse P; Lemaitre J; Kahlaoui N; Delache B; Pizzorno A; Nougairede A; Ludot C; Terrier O; Dereuddre-Bosquet N; Relouzat F; Chapon C; Ho Tsong Fang R; van der Werf S; Rosa Calatrava M; Malvy D; de Lamballerie X; Guedj J; Le Grand R
Nat Commun; 2022 Aug; 13(1):5108. PubMed ID: 36042198
[TBL] [Abstract][Full Text] [Related]
5. Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?
Sessions Z; Bobrowski T; Martin HJ; Beasley JT; Kothari A; Phares T; Li M; Alves VM; Scotti MT; Moorman NJ; Baric R; Tropsha A; Muratov EN
FEMS Microbiol Rev; 2023 Sep; 47(5):. PubMed ID: 37596064
[TBL] [Abstract][Full Text] [Related]
6. Host Cell Targets for Unconventional Antivirals against RNA Viruses.
Roa-Linares VC; Escudero-Flórez M; Vicente-Manzanares M; Gallego-Gómez JC
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992484
[TBL] [Abstract][Full Text] [Related]
7. Nipah Outbreak: Is it the beginning of another pandemic in the era of COVID-19 and Zika.
Thakur V; Thakur P; Ratho RK
Brain Behav Immun; 2022 Jan; 99():25-26. PubMed ID: 34562598
[No Abstract] [Full Text] [Related]
8. DEAD-Box Helicase DDX3X as a Host Target against Emerging Viruses: New Insights for Medicinal Chemical Approaches.
Brai A; Trivisani CI; Poggialini F; Pasqualini C; Vagaggini C; Dreassi E
J Med Chem; 2022 Aug; 65(15):10195-10216. PubMed ID: 35899912
[TBL] [Abstract][Full Text] [Related]
9. Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection.
Lin MH; Li D; Tang B; Li L; Suhrbier A; Harrich D
Microbiol Spectr; 2022 Dec; 10(6):e0394922. PubMed ID: 36445148
[TBL] [Abstract][Full Text] [Related]
10. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
[TBL] [Abstract][Full Text] [Related]
11. Viral immunity: Basic mechanisms and therapeutic applications-a Keystone Symposia report.
Cable J; Balachandran S; Daley-Bauer LP; Rustagi A; Antony F; Frere JJ; Strampe J; Kedzierska K; Cannon JL; McGargill MA; Weiskopf D; Mettelman RC; Niessl J; Thomas PG; Briney B; Valkenburg SA; Bloom JD; Bjorkman PJ; Iketani S; Rappazzo CG; Crooks CM; Crofts KF; Pöhlmann S; Krammer F; Sant AJ; Nabel GJ; Schultz-Cherry S
Ann N Y Acad Sci; 2023 Mar; 1521(1):32-45. PubMed ID: 36718537
[TBL] [Abstract][Full Text] [Related]
12. Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
Jans DA; Wagstaff KM
Cells; 2020 Sep; 9(9):. PubMed ID: 32942671
[TBL] [Abstract][Full Text] [Related]
13. Innate immune pathway modulator screen identifies STING pathway activation as a strategy to inhibit multiple families of arbo and respiratory viruses.
Garcia G; Irudayam JI; Jeyachandran AV; Dubey S; Chang C; Castillo Cario S; Price N; Arumugam S; Marquez AL; Shah A; Fanaei A; Chakravarty N; Joshi S; Sinha S; French SW; Parcells MS; Ramaiah A; Arumugaswami V
Cell Rep Med; 2023 May; 4(5):101024. PubMed ID: 37119814
[TBL] [Abstract][Full Text] [Related]
14. Broadly Active Antiviral Compounds Disturb Zika Virus Progeny Release Rescuing Virus-Induced Toxicity in Brain Organoids.
Pettke A; Tampere M; Pronk R; Wallner O; Falk A; Warpman Berglund U; Helleday T; Mirazimi A; Puumalainen MR
Viruses; 2020 Dec; 13(1):. PubMed ID: 33383826
[TBL] [Abstract][Full Text] [Related]
15. In vitro broad-spectrum antiviral activity of MIT-001, a mitochondria-targeted reactive oxygen species scavenger, against severe acute respiratory syndrome coronavirus 2 and multiple zoonotic viruses.
Lim T; Rajoriya S; Kim B; Natasha A; Im H; Shim HS; Yoo J; Kim JW; Lee EW; Shin HJ; Kim SH; Kim WK
Virus Res; 2024 Apr; 342():199325. PubMed ID: 38309472
[TBL] [Abstract][Full Text] [Related]
16. [Viral infections in urology].
Magistro G; Pilatz A; Schneede P; Schneidewind L; Wagenlehner F
Urologe A; 2021 Sep; 60(9):1150-1158. PubMed ID: 34228144
[TBL] [Abstract][Full Text] [Related]
17. The Importance of Biobanking for Response to Pandemics Caused by Emerging Viruses: The European Virus Archive As an Observatory of the Global Response to the Zika Virus and COVID-19 Crisis.
Coutard B; Romette JL; Miyauchi K; Charrel R; Prat CMA;
Biopreserv Biobank; 2020 Dec; 18(6):561-569. PubMed ID: 33181021
[TBL] [Abstract][Full Text] [Related]
18. Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis.
Rajput A; Thakur A; Rastogi A; Choudhury S; Kumar M
Comput Biol Med; 2021 Sep; 136():104677. PubMed ID: 34332351
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 RNAs are processed into 22-nt vsRNAs in Vero cells.
Liu Y; Rao J; Mi Y; Chen L; Feng L; Li Q; Geng J; Yang X; Zhan X; Ren L; Chen J; Zhang X
Front Immunol; 2022; 13():1008084. PubMed ID: 36389816
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of viral infection outcomes in human seminal fluid from prior viral epidemics and Sars-CoV-2 may offer trends for viral sexual transmissibility and long-term reproductive health implications.
Pike JFW; Polley EL; Pritchett DY; Lal A; Wynia BA; Roudebush WE; Chosed RJ
Reprod Health; 2021 Jun; 18(1):123. PubMed ID: 34112171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
